MRNA vs SNFCA · rev $145.0M vs P/E 7.5, rev $163.7M
Moderna Inc (MRNA) versus Security National Financial (SNFCA) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Security National Financial (SNFCA) is a insurance - life company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SNFCA revenue for 2026-06-30 was $163.7M. Net income was $16.0M. SNFCA currently screens at market cap $251.0M and trailing P/E 7.5.
MRNA currently screens at market cap $24.52B. SNFCA currently screens at market cap $251.0M and trailing P/E 7.5.
Not investment advice. Open the MRNA and SNFCA stock pages for the full models.
Not investment advice.